It's hard to disagree with the fact that GLUC is thinly traded. That said, if buyers did come in en mass the price would definitely move up.
The question then becomes what will attract buyers?
Yesterday's Q3 report should have provided that catalyst. Not sure that there is anything better than an OTC company with strong revenue growth, and a kick-ass product on Amazon.
Add to that, a very compelling capital structure with no debt, low float and a small number of shares outstanding.
Oh, and BTW the company has shown that it can be profitable.
How many OTC pink sheet companies can say that?